- $1.35bn
- $1.60bn
- $466.15m
- 88
- 45
- 40
- 59
Annual income statement for N-Able, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 303 | 346 | 372 | 422 | 466 |
Cost of Revenue | |||||
Gross Profit | 240 | 294 | 313 | 354 | 385 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 269 | 313 | 324 | 352 | 384 |
Operating Profit | 33.8 | 33.3 | 47.4 | 70.3 | 82.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.86 | 11.6 | 30.4 | 44.3 | 54.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.16 | 0.113 | 16.7 | 23.4 | 31 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.16 | 0.113 | 16.7 | 23.4 | 31 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.16 | 0.113 | 16.7 | 23.4 | 31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.045 | 0.001 | 0.106 | 0.131 | 0.191 |
Dividends per Share |